SV1994000031A - Derivados de 1,5 benzodiacepina ref. 1160ch/sv - Google Patents
Derivados de 1,5 benzodiacepina ref. 1160ch/svInfo
- Publication number
- SV1994000031A SV1994000031A SV1994000031A SV1994000031A SV1994000031A SV 1994000031 A SV1994000031 A SV 1994000031A SV 1994000031 A SV1994000031 A SV 1994000031A SV 1994000031 A SV1994000031 A SV 1994000031A SV 1994000031 A SV1994000031 A SV 1994000031A
- Authority
- SV
- El Salvador
- Prior art keywords
- carbon
- atoms
- rent
- hydroxy
- replaced
- Prior art date
Links
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 16
- 229910052799 carbon Inorganic materials 0.000 abstract 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 6
- -1 PHENYL GROUP Chemical group 0.000 abstract 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 3
- 229910052757 nitrogen Inorganic materials 0.000 abstract 3
- 229910052760 oxygen Inorganic materials 0.000 abstract 3
- 239000001301 oxygen Substances 0.000 abstract 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 239000011593 sulfur Substances 0.000 abstract 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- 229940037003 alum Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical group [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical class [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen(.) Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
EL PRESENTE INVENTO SE RELACIONA CON UN COMPUESTO DE LA FORMULA GENERAL I, VER FORMULA, CARACTERIZADO PORQUE R1 REPRESENTA UN GRUPO FENILO, CICLOAQUILO CON 3 A 7 ATOMOS DE CARBONO, CICLOALQUILO CON 7 A 11 ATOMOS DE CARBONO, UNIDO POR MEDIO DE UN PUENTE O ALQUILO CON 1 A 6 ATOMOS DE CARBONO, TAL GRUPO ALQUILO PUEDE ESTAR SUSTITUIDO POR UN GRUPO HIDROXI, FENILO, ALCOXICARBONILO CON 1 A 6 ATOMOS DE CARBONO, CICLOALQUILO CON 3 A 7 ATOMOS DE CARBONO, O CICLOAQUILO CON 7 A 11 ATOMOS DE CARBONO, UNIDO POR MEDIOS DE UN PUENTE; R2 REPRESENTA UN GRUPO FENILO OPCIONALMENTE SUSTITUIDO POR 1 ó 2 SUSTITUYENTES SELECCIONADOS DE HOLOGENO, ALQUILO CON 1 A 4 ATOMOS DE CARBONO, ALQUILTIO CON 1 A 4 ATOMOS DE CARBONO, CIANO, NITRO, TRIFLUOROETILO, TRIFLUOROMETOXI, (CH2)nR4 U O(CH2)pR4, DONDE R4 REPRESENTA HIDROXI, ALCOXI CON 1 A 4 ATOMOSD E CARBONO, CO2R5 O NR6R7; N ES CERO ó 1; p ES UN ENTERO DESD4E 1 HASTA 4; R3 REPRESENTA EL GRUPO ALqNR8R9; R5 REPRESENTA HIDROGENO O ALQUILO CON 1 A 4 ATOMOS DE CARBONO; R6 REPRESENTA HIDROGENO O ALQUILO CON 1 A 4 ATOMOS DE CARBONO; R7 REPRESENTA HIDROGENO, ALQUILO CON 1 A 4 ATOMOS DE CARBONO, ACILO, O ALQUILO CON 2 A 6 ATOMOS DE CARBONO, SUSTITUIDO POR UNO O MAS GRUPOS HIDROXI, CARBOXILO Y/O AMINO R6 Y R7 JUNTO CON EL ATOMO DE NITROGENO AL CUAL LOS MISMOS ESTAN UNIDOS, FORMAN UN ANILLO HETEROCICLICO SATURADO CON 5-7 ELEMENTOS, EL CUAL CONTIENE UN HETEROATOMO ADICIONAL SELECCIONADO DE OXIGENO, AZUFRE O NITROGENO Y/O PUEDE ESTAR SUSTITUIDO POR 1 ó 2 GRUPOS HIDROXI O ALQUILO CON 1 A 4 ATOMOS DE CARBONO; R8 Y R9 REPRESENTAN INDEPENDIENTEMENTE HIDROGENO, ALQUILO CON 1 A 4 ATOMOS DE CARBONO O ALQUILO CON 2 A 6 ATOMOS DE CARBONO, SUSTITUIDO POR UNO O MAS GRUPOS HIDROXI, CARBOXILO Y/O AMINO O R8 Y R9 JUNTO CON EL ATOMO DE NITROGENO AL CUAL LOS MISMOS ESTAN UNIDOS, REPRESENTAN UN ANILLO HETEROCICLICO SATURADO CON 5-7 ELEMENTOS, EL CUAL PUEDE CONTENER UN HETEROATOMO ADICIONAL SELECCIOANDO DE OXIGENO, AZUFRE O NITROGENO Y/O PUEDE ESTAR SUSTITUIDO POR 1 ó 2 GRUOS HIDROXI O ALQUILO CON 1 A 4 ATOMOS DE CARBONO, ALq REPRESETA UNA CADENA DE ALQUILENO CON 2 A 6 ATOMOS DE CARBONO, RECTA O RAMIFICADA, SUSTITUIDA OPCIONALMENTE POR UN HIDROXILO; R10 REPRESENTA HIDROGENO O UN ATOMO DE HALOGENO, M ES CERO, 1 ó 2; X ES OXIGENO O NH; Y SUS SALES ACEPTABLES FARMACEUTICAMENTE Y/O ESTERES METABOLICAMENTE LABILES DE LOS MISMOS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939314981A GB9314981D0 (en) | 1993-07-20 | 1993-07-20 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SV1994000031A true SV1994000031A (es) | 1995-10-04 |
Family
ID=10739096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SV1994000031A SV1994000031A (es) | 1993-07-20 | 1994-07-19 | Derivados de 1,5 benzodiacepina ref. 1160ch/sv |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US5716953A (es) |
| EP (1) | EP0710230B1 (es) |
| JP (1) | JP3587849B2 (es) |
| KR (1) | KR100347287B1 (es) |
| CN (1) | CN1050835C (es) |
| AP (1) | AP492A (es) |
| AT (1) | ATE171167T1 (es) |
| AU (1) | AU687858B2 (es) |
| CA (1) | CA2167308A1 (es) |
| CO (1) | CO4290299A1 (es) |
| CZ (1) | CZ290472B6 (es) |
| DE (1) | DE69413405T2 (es) |
| DK (1) | DK0710230T3 (es) |
| EC (1) | ECSP941120A (es) |
| ES (1) | ES2123812T3 (es) |
| FI (1) | FI960223A7 (es) |
| GB (1) | GB9314981D0 (es) |
| HR (1) | HRP940411B1 (es) |
| HU (1) | HU222439B1 (es) |
| IL (1) | IL110366A (es) |
| IS (1) | IS4190A (es) |
| MY (1) | MY118638A (es) |
| NO (1) | NO313288B1 (es) |
| NZ (1) | NZ271075A (es) |
| PE (1) | PE8295A1 (es) |
| PL (1) | PL175609B1 (es) |
| RU (1) | RU2135485C1 (es) |
| SI (1) | SI0710230T1 (es) |
| SV (1) | SV1994000031A (es) |
| TW (1) | TW290542B (es) |
| WO (1) | WO1995003285A1 (es) |
| ZA (1) | ZA945238B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5739129A (en) * | 1994-04-14 | 1998-04-14 | Glaxo Wellcome Inc. | CCK or gastrin modulating 5-heterocyclic-1, 5 benzodiazepines |
| PE27497A1 (es) * | 1994-04-15 | 1997-08-07 | Glaxo Inc | Derivados de 1,5 benzodiazepina |
| WO1998002419A1 (en) * | 1996-07-12 | 1998-01-22 | Chugai Seiyaku Kabushiki Kaisha | Cancer cell proliferation inhibitors |
| US6683075B1 (en) | 1996-12-23 | 2004-01-27 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use |
| US6635632B1 (en) | 1996-12-23 | 2003-10-21 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| US20030190307A1 (en) | 1996-12-24 | 2003-10-09 | Biogen, Inc. | Stable liquid interferon formulations |
| US6958330B1 (en) | 1998-06-22 | 2005-10-25 | Elan Pharmaceuticals, Inc. | Polycyclic α-amino-ε-caprolactams and related compounds |
| US6569851B1 (en) * | 1998-06-22 | 2003-05-27 | Elan Pharmaceutials, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| DE60009116T2 (de) | 1999-10-15 | 2005-02-17 | F. Hoffmann-La Roche Ag | Benzodiazepinderivate und deren verwendung als metabotrope glutamatrezeptor antagonisten |
| US20050192265A1 (en) * | 2003-03-20 | 2005-09-01 | Thompson Richard C. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| MXPA06003870A (es) * | 2003-10-06 | 2006-07-03 | Hoffmann La Roche | Derivados de dibenzo-azepina y benzo-diazepina substituidas utiles como inhibidores de gama-secretasa. |
| EP1722711A4 (en) * | 2004-02-27 | 2009-12-02 | Aortx Inc | SYSTEMS AND METHOD FOR STORING ARTIFICIAL HEART FLAPS |
| EP2137167B1 (en) * | 2007-04-19 | 2011-08-10 | F. Hoffmann-La Roche AG | Dihydro-benzo[b][1,4]diazepin-2-one sulfonamide derivatives |
| RU2540464C2 (ru) * | 2012-05-28 | 2015-02-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации | Водорастворимое производное амида салициловой кислоты, обладающее транквилизирующей, ноотропной и анальгезирующей активностью |
| CN103435562B (zh) * | 2013-08-26 | 2016-02-24 | 华东理工大学 | 6-取代苯并二氮卓-2,4-二酮类化合物及其用途 |
| RU2702359C1 (ru) * | 2019-06-04 | 2019-10-08 | Федеральное государственное бюджетное научное учреждение Уфимский федеральный исследовательский центр Российской академии наук | Способ получения 2,2,4-триалкил-2,3-дигидро-1Н-1,5-бензодиазепинов |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2103745A1 (de) * | 1971-01-27 | 1972-08-10 | CH. Boehringer Sohn, 6507 Ingelheim | Neue 5-AryJ-(bzw. Heteroaryl)-3-hydroxylH-l,5-benzodiazepin-2,4-(3H,5H)-dioneund Verfahren zu ihrer Herstellung |
| FR2641280B1 (fr) * | 1988-12-29 | 1994-01-21 | Roussel Uclaf | Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments |
| CA2068355A1 (en) * | 1991-05-14 | 1992-11-15 | Mark S. Chambers | Benzodiazephine derivatives, compositions containing them and their use in therapy |
| GEP20001968B (en) * | 1992-01-21 | 2000-03-05 | Glaxo Spa | Arilthio Compounds as Antibacterial and Antiviral Agents |
| GB9201181D0 (en) * | 1992-01-21 | 1992-03-11 | Glaxo Spa | Chemical compounds |
| GB9225492D0 (en) * | 1992-12-05 | 1993-01-27 | Glaxo Group Ltd | Amine derivatives |
-
1993
- 1993-07-20 GB GB939314981A patent/GB9314981D0/en active Pending
-
1994
- 1994-07-15 IS IS4190A patent/IS4190A/is unknown
- 1994-07-18 AT AT94924257T patent/ATE171167T1/de not_active IP Right Cessation
- 1994-07-18 HU HU9600124A patent/HU222439B1/hu not_active IP Right Cessation
- 1994-07-18 JP JP50492695A patent/JP3587849B2/ja not_active Expired - Fee Related
- 1994-07-18 MY MYPI94001865A patent/MY118638A/en unknown
- 1994-07-18 WO PCT/EP1994/002353 patent/WO1995003285A1/en not_active Ceased
- 1994-07-18 DE DE69413405T patent/DE69413405T2/de not_active Expired - Fee Related
- 1994-07-18 SI SI9430207T patent/SI0710230T1/xx not_active IP Right Cessation
- 1994-07-18 CA CA002167308A patent/CA2167308A1/en not_active Abandoned
- 1994-07-18 AP APAP/P/1994/000657A patent/AP492A/en active
- 1994-07-18 KR KR1019960700279A patent/KR100347287B1/ko not_active Expired - Fee Related
- 1994-07-18 EC EC1994001120A patent/ECSP941120A/es unknown
- 1994-07-18 CZ CZ1996173A patent/CZ290472B6/cs not_active IP Right Cessation
- 1994-07-18 AU AU74589/94A patent/AU687858B2/en not_active Ceased
- 1994-07-18 PE PE1994246888A patent/PE8295A1/es not_active Application Discontinuation
- 1994-07-18 ES ES94924257T patent/ES2123812T3/es not_active Expired - Lifetime
- 1994-07-18 US US08/578,535 patent/US5716953A/en not_active Expired - Fee Related
- 1994-07-18 RU RU96102670A patent/RU2135485C1/ru not_active IP Right Cessation
- 1994-07-18 PL PL94312659A patent/PL175609B1/pl not_active IP Right Cessation
- 1994-07-18 NZ NZ271075A patent/NZ271075A/en unknown
- 1994-07-18 DK DK94924257T patent/DK0710230T3/da active
- 1994-07-18 HR HR940411A patent/HRP940411B1/xx not_active IP Right Cessation
- 1994-07-18 ZA ZA945238A patent/ZA945238B/xx unknown
- 1994-07-18 CN CN94193283A patent/CN1050835C/zh not_active Expired - Fee Related
- 1994-07-18 EP EP94924257A patent/EP0710230B1/en not_active Expired - Lifetime
- 1994-07-18 CO CO94031454A patent/CO4290299A1/es unknown
- 1994-07-19 SV SV1994000031A patent/SV1994000031A/es active IP Right Grant
- 1994-07-19 IL IL11036694A patent/IL110366A/en not_active IP Right Cessation
- 1994-07-22 TW TW083106738A patent/TW290542B/zh active
-
1996
- 1996-01-17 FI FI960223A patent/FI960223A7/fi unknown
- 1996-01-19 NO NO19960237A patent/NO313288B1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SV1994000031A (es) | Derivados de 1,5 benzodiacepina ref. 1160ch/sv | |
| ES2058809T3 (es) | Derivados heterociclicos. | |
| DK0457686T3 (da) | Hidtil ukendte aminopiperidin-, aminopyrrolidin- og aminoperhydroazepinderivater, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| KR960701019A (ko) | 신규의 4-아미노피리딘, 이것의 제조방법 및 이것을 함유하는 약제(new 4-aminopyridines, process for preparing the same and me-dicaments containing the same) | |
| AR012315A1 (es) | Derivados de ditiolan y el uso de los mismos en la fabricacion de un medicamento. | |
| CO4960641A1 (es) | Derivados de piperidina 1,4-disustituida conteniendo fluor | |
| ES2055056T3 (es) | Derivados de pirimidopirimidina. | |
| MX9300988A (es) | Agentes antineoplasticos de quinobenzoxazina, quinobenzotiazina y pirido-acridina y composicion farmaceutica que los contiene. | |
| ES2095942T3 (es) | Derivados de bencenoacetamida inhibidores del vih. | |
| ATE165095T1 (de) | Heterocyclische derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| DK0406119T3 (da) | Hidtil ukendte peptidderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem | |
| DE59209553D1 (de) | 1,7-anellierte 3-(Piperazino-alkyl)indol-Derivate sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DK29285D0 (da) | Methylendiphosphonsyrederivater og fremgangsmaade til fremstilling deraf samt antireumatiske farmaceutiske midler indeholdende derivaterne | |
| ES2056073T3 (es) | Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende. | |
| CO4480026A1 (es) | Nuevos compuestos que inhiben la accion de la lipoxigenasa y composiciones farmaceuticas que los contienen . . . | |
| ES2162856T3 (es) | Derivados de ergolina serotoninergicos. | |
| CO5080785A1 (es) | Derivados heterociclicos | |
| DE69430618D1 (de) | Cephemverbindungen | |
| CO4970746A1 (es) | Nuevos compuestos sustituidos de benzoisotiazol para tratamiento de estados mediados por la quimioquina | |
| ES2183434T3 (es) | Derivados de cromano sustituidos con carboxilo utiles como agonistas de adrenoreceptores. | |
| ES2032985T3 (es) | Nuevos tripeptidos de estructura policiclica nitrogenada, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| DK0486385T3 (da) | Imidazolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| ES2174582T3 (es) | Nuevos derivados de 1,2-ditiolano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ATE93861T1 (de) | Synthese von beta-lactamverbindungen. | |
| ATE116291T1 (de) | Oxysulfonylcarbamate. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant |